Cresco Labs (CRLBF) Operating Income (2020 - 2026)
Cresco Labs (CRLBF) posted Operating Income of $11.2 million for Q1 2026, up 114.79% on a QoQ basis from -$75.5 million in Q4 2025, and down 17.78% year-over-year from $13.6 million in Q1 2025.
Cresco Labs (CRLBF) Operating Income (2020 - 2026) Analysis & Trends
Cresco Labs' Operating Income history runs 7 years deep, the most recent figure standing at $11.2 million for Q1 2026.
- Quarterly Operating Income fell 17.78% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.4 million (down 133.15% YoY) and the FY2025 annual result came in at -$28.0 million, down 126.08% from the prior year.
- Operating Income was $11.2 million for Q1 2026 at Cresco Labs, up from -$75.5 million in the prior quarter.
- Across five years, Operating Income topped out at $32.4 million in Q2 2024 and bottomed at -$143.5 million in Q4 2022.
- A 5-year average of -$4.8 million and a median of $16.2 million in 2022 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income plunged 1022.28% — and 2024, when it surged 713.25%.
- Cresco Labs' Operating Income stood at -$143.5 million in 2022, then jumped by 118.89% to $27.1 million in 2023, then declined by 28.39% to $19.4 million in 2024, then tumbled by 489.29% to -$75.5 million in 2025, then jumped by 114.79% to $11.2 million in 2026.
- Business Quant data shows CRLBF's Operating Income at $11.2 million in Q1 2026, -$75.5 million in Q4 2025, and $17.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 325.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Cresco Labs | 247.68 Mn | 184.10 Mn | 75.45 Mn | 11.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.17 Mn |
| Dec 31, 2025 | -75.55 Mn |
| Sep 30, 2025 | 17.83 Mn |
| Jun 30, 2025 | 16.14 Mn |
| Mar 31, 2025 | 13.59 Mn |
| Dec 31, 2024 | 19.41 Mn |
| Sep 30, 2024 | 26.34 Mn |
| Jun 30, 2024 | 32.38 Mn |
| Mar 31, 2024 | 29.16 Mn |
| Dec 31, 2023 | 27.10 Mn |
| Sep 30, 2023 | -107.76 Mn |
| Jun 30, 2023 | -10.75 Mn |
| Mar 31, 2023 | 3.59 Mn |
| Dec 31, 2022 | -143.48 Mn |
| Sep 30, 2022 | 16.24 Mn |
| Jun 30, 2022 | 22.68 Mn |
| Mar 31, 2022 | 20.27 Mn |
| Dec 31, 2021 | 15.56 Mn |
| Sep 30, 2021 | -264.02 Mn |
| Jun 30, 2021 | 14.87 Mn |